
Overview
Medtech is a company operating at the intersection of medicine and technology. It supplies orthopedic implants and develops AI solutions for healthcare, including RefferAI for prescreening patients for clinical trials. Its offer also includes MTag devices and cooperation with global medical device manufacturers.
Financials
Revenue history (in k)
Financial insight
- The statement flags a going concern risk. Zarząd wskazuje ryzyka związane z wdrażaniem nowego modelu przychodowego i płynnością, lecz uznaje, że istnieją racjonalne podstawy do kontynuowania działalności.
From the notes
| Current income tax (CIT due) | $0 | |
| Profit allocation | Loss to be covered |
Filing timeliness
1 of 6 financial statements was filed late (for 2025, 99 days late). All were audited by a statutory auditor.
- 202522/10/2026
- 202403/07/2025
- 202311/07/2024
- 202224/05/2023
- 202114/07/2022
- 202009/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Sanctions and PEP lists
| Person | List | Match | |
|---|---|---|---|
| Mariusz Furmanek | Szef Obrony Cywilnej Kraju | confirmed |
Stock quotes
- Open
- PLN 0.47
- High
- PLN 0.47
- Low
- PLN 0.42
- Volume
- 1.04M
- Avg. vol.
- 1.84M
- Market cap
- PLN 32.16M
- P/E ratio
- –
- EPS
- -PLN 0.05
- Shares outstanding
- 75.5M
- 52-week
- PLN 0.35 – 0.52
- Dividend yield
- –
- Dividend
- –
- Ex dividend date
- –
- ISIN
- PLCCHT000014
- Exchange
- NewConnect
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q3 2026 | USD 56.46k | USD -99.68k | USD -101.84k |
| Q2 2026 | USD 110.75k | USD -95.62k | USD -97.51k |
| Q1 2026 | USD 99.41k | USD -94.27k | USD -94.27k |
| Q4 2025 | USD 49.97k | USD -404.57k | USD -406.83k |
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Patient recruitment software
- Medical records analysis
- Patient screening for clinical trials
Websites
- medtechs.plMedtech
Public procurement
1 tender recorded as contractor, with a total value of $88,716.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Jan 19, 2026 | Purchase and delivery of primary and revision hip joint endoprostheses | $88,716$88,716 | Samodzielny Publiczny Zakład Opieki Zdrowotnej - Szpital Powiatowy w Piszu |
The company is the contractor in 3 public sector contracts, worth USD 63.83k in total. They were signed with 2 public buyers.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Sep 17, 2026 | Purchase of implantable products. | $37.52 | Zespół Zakładów Opieki Zdrowotnej w Wadowicach | |
| Sep 11, 2026 | Purchase of implantable products. | $47.53 | Zespół Zakładów Opieki Zdrowotnej w Wadowicach | |
| Aug 27, 2026 | The subject of the contract is the purchase and delivery to the Contracting Authority’s registered office of endoprostheses and implants, together with the lease of instrumentation, for Samodzielny Publiczny Wojewódzki Szpital Chirurgii Urazowej im. dr. Janusza Daaba w Piekarach Śląskich (Part 2), in accordance with the price form constituting Annex 1 to this contract and the tender submitted by the Contractor in procedure No. SZP.270-24/2026 – Lot 18 – Plates. | $63,749 | Samodzielny Publiczny Wojewódzki Szpital Chirurgii Urazowej Im.Dr.Janusza Daaba w Piekarach Śląskich |
Job offers
The company has its own careers page: medtechs.pl/firma/kariera.
Authorized Representatives
Manner of representation
In the case of a one-person management board, the sole member of the management board is authorised to make declarations of will and sign on behalf of the company, whereas in the case of a multi-member management board, the President of the Management Board is authorised to do so independently, while the Vice-President is authorised to do so jointly with a second member of the management board or with a commercial proxy.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2015-09-09.
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Oct 23, 2026 | Commercial Companies Code notice | |
| Jun 6, 2017 | Shareholders' meeting convened |
Public aid
4 public aid cases recorded, with a total value of $9,933.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 19, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| Dec 9, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| Dec 9, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Lifestyle-Med sp. z o.o. | $146,784.32 | lifestyle-med.pl | ||
| NARF sp. z o.o. | $142,888.02 | narf.ai | ||
| Actuaro sp. z o.o. | $139,908.62 | actuaro.pl | ||
| Heroify sp. z o.o. | $133,752.95 | heroify.co | ||
| Hector Labs sp. z o.o. | $123,526.91 | hectorlabs.io | ||
| Medway Health Innovation & Service sp. z o.o. | $101,080.04 | medway.pl | ||
| Deeptech sp. z o.o. | $92,581.79 | deeptech.pl | ||
| Infotower Technologies sp. z o.o. | $90,348.84 | technologies.infotower.pl | ||
| Simmundi sp. z o.o. | $85,415.15 | simmundi.pl | ||
| Argocloud sp. z o.o. | $81,697.48 | argocloud.eu |
Change history
| Date | Event | |
|---|---|---|
| 2026-05-26 | Address change (Rondo Ignacego Daszyńskiego 2b/Omnioffice, 00-843, Warszawa → Ul. Żelazna 59a/3.3, 00-848, Warszawa) | |
| 2025-08-07 | Address change (Ul. Długa 29, 00-238, Warszawa → Rondo Ignacego Daszyńskiego 2b/Omnioffice, 00-843, Warszawa) | |
| 2025-08-07 | Share capital increase (1,510,000.00 PLN → 7,550,000.00 PLN) | |
| 2025-03-27 | Share capital increase (1,000,000.00 PLN → 1,510,000.00 PLN) | |
| 2025-03-10 | Share capital reduction (14,000,000.00 PLN → 1,000,000.00 PLN) |
FAQ
Last updated: 2026-10-22
